top of page
About
Our Company
Our Leadership Team
Science
Our Technology
DNA Methylation
Exosomes
Products
Our Portfolio
Laboratory Developed Tests Services
Eye Care
Clinical Trial Drug Distribution
Health Supplements
Pipeline
Newsroom
Contact
Investors
More
Use tab to navigate through the menu items.
Newsroom
All Posts
Publication
News
Leadership Story
SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer
Oct 7, 2020
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
May 12, 2020
Hypermethylation of BEND5 contributes to cell proliferation andis a prognostic marker of colorectal cancer
Nov 1, 2017
Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer
Aug 19, 2014
Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer
Jul 15, 2010
bottom of page
